CIC
GBIO

Cornercap Investment Counsel’s Generation Bio GBIO Stock Holding History

Cornercap Investment Counsel’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,900
Closed -$71.6K – 498
2024
Q3 		$71.6K Sell
2,900
-2,842
-49% -$75.2K 0.02% 497
2024
Q2 		$162K Sell
5,742
-1,675
-23% -$54.4K 0.03% 552
2024
Q1 		$302K Buy
7,417
+3,571
+93% +$84.1K 0.05% 516
2023
Q4 		$63.5K Buy
3,846
+78
+2% +$1.36K 0.01% 562
2023
Q3 		$143K Sell
3,768
-38
-1% -$1.8K 0.03% 519
2023
Q2 		$209K Buy
3,806
+939
+33% +$43.1K 0.04% 504
2023
Q1 		$123K Buy
2,867
+15
+0.5% +$725 0.02% 534
2022
Q4 		$112K Buy
2,852
+17
+0.6% +$893 0.02% 531
2022
Q3 		$151K Buy
2,835
+349
+14% +$21.8K 0.03% 513
2022
Q2 		$163K Buy
+2,486
New +$163K 0.03% 497

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Cornercap Investment Counsel's GBIO Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Generation Bio (GBIO) in Q4 2024, closing a stake of 2,900 shares — an estimated $71.6K sold.

Cornercap Investment Counsel first reported a position in GBIO in Q2 2022 and held it in 10 quarters. The position peaked at $302K in Q1 2024. 78 funds tracked by Wall St. Rank hold GBIO as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Generation Bio position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 2,900 Generation Bio shares in Q4 2024, an estimated $71.6K.
  • Cornercap Investment Counsel first reported a position in Generation Bio in Q2 2022 and held it in 10 quarters.
  • Cornercap Investment Counsel's Generation Bio position peaked at $302K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Generation Bio as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.